177 related articles for article (PubMed ID: 32621327)
1. Systematic review and meta-analysis of the metabolic effects of modified-release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency.
Bannon CA; Gallacher D; Hanson P; Randeva HS; Weickert MO; Barber TM
Clin Endocrinol (Oxf); 2020 Dec; 93(6):637-651. PubMed ID: 32621327
[TBL] [Abstract][Full Text] [Related]
2. Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency.
Bannon CAM; Border D; Hanson P; Hattersley J; Weickert MO; Grossman A; Randeva HS; Barber TM
Front Endocrinol (Lausanne); 2021; 12():641247. PubMed ID: 33776936
[TBL] [Abstract][Full Text] [Related]
3. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
4. GLUCOCORTICOID REPLACEMENT REGIMENS IN CHRONIC ADRENAL INSUFFICIENCY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Al Nofal A; Bancos I; Benkhadra K; Ospina NM; Javed A; Kapoor E; Muthusamy K; Brito JP; Turcu AF; Wang Z; Prokop L; Erickson DZ; Lteif AN; Natt N; Murad MH
Endocr Pract; 2017 Jan; 23(1):17-31. PubMed ID: 27631672
[TBL] [Abstract][Full Text] [Related]
5. Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis.
Guarnotta V; Ciresi A; Pillitteri G; Giordano C
Clin Endocrinol (Oxf); 2018 May; 88(5):665-672. PubMed ID: 29368442
[TBL] [Abstract][Full Text] [Related]
6. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
[TBL] [Abstract][Full Text] [Related]
8. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review.
Caetano CM; Malchoff CD
Front Endocrinol (Lausanne); 2022; 13():897211. PubMed ID: 35846313
[TBL] [Abstract][Full Text] [Related]
9. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
[TBL] [Abstract][Full Text] [Related]
10. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
12. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
[TBL] [Abstract][Full Text] [Related]
15. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
[TBL] [Abstract][Full Text] [Related]
16. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
17. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
Gow R; Koren G; Rieder M; Van Uum S
Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
[TBL] [Abstract][Full Text] [Related]
18. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP; Mallappa A; Arlt W; Brac de la Perriere A; Lindén Hirschberg A; Juul A; Newell-Price J; Perry CG; Prete A; Rees DA; Reisch N; Stikkelbroeck N; Touraine P; Maltby K; Treasure FP; Porter J; Ross RJ
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2063-e2077. PubMed ID: 33527139
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
[TBL] [Abstract][Full Text] [Related]
20. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
Dineen R; Stewart PM; Sherlock M
Clin Endocrinol (Oxf); 2019 Jan; 90(1):3-14. PubMed ID: 30120786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
